8.88
+0.15
+(1.72%)
At close: January 10 at 5:30:32 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | 0 | 0 | 1.82 | -1.03 |
| Low Estimate | 0 | 0 | 1.49 | -1.79 |
| High Estimate | 0 | 0 | 2.15 | -0.27 |
| Year Ago EPS | -- | -- | -0.91 | 1.82 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 3 | 3 |
| Avg. Estimate | -- | -- | 42.87M | 13.51M |
| Low Estimate | -- | -- | 24.3M | 7.33M |
| High Estimate | -- | -- | 53.3M | 18M |
| Year Ago Sales | -- | -- | 9.06M | 42.87M |
| Sales Growth (year/est) | -- | -- | 373.29% | -68.48% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 1.82 | -1.03 |
| 7 Days Ago | 0 | 0 | 1.33 | 0.46 |
| 30 Days Ago | 0 | 0 | 1.33 | 0.46 |
| 60 Days Ago | 0 | 0 | 1.33 | 0.46 |
| 90 Days Ago | 0 | 0 | 1.33 | 0.46 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NWRN.SW | -- | -- | 300.00% | -156.59% |
| S&P 500 | 8.66% | 11.51% | 14.05% | 13.39% |
Related Tickers
MOLN.SW Molecular Partners AG
4.5450
-1.94%
SANN.SW Santhera Pharmaceuticals Holding AG
13.68
-2.84%
TTI.V Thiogenesis Therapeutics, Corp.
0.5700
-1.72%
EVE.SW Evolva Holding SA
1.1000
-5.58%
IDIA.SW Idorsia Ltd
0.7790
-1.77%
RLF.SW Relief Therapeutics Holding SA
3.8500
-1.53%
SPEX.SW Spexis AG
0.0570
0.00%
ADXN.SW Addex Therapeutics Ltd
0.0640
+6.31%
0DPB.IL Bavarian Nordic A/S
202.35
-0.92%
PTP.DE Pentixapharm Holding AG N
2.9900
-0.33%